Rosetta Genomics Says ‘Technical Obstacles’ Will Delay Colorectal Cancer Screen Launch
September 10, 2009
Rosetta Genomics Says ‘Technical Obstacles’ Will Delay Colorectal Cancer Screen Launch
Rosetta also said that CEO Amir Avniel intends to step down in order to take the reins of Rosetta’s roughly year-old plant biotechnology unit, Rosetta Green. The disclosures were made as the company reported its second-quarter financial results.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Rosetta Posts Lower Q1 Losses on Decreased Costs
June 9, 2011 / Gene Silencing News - Rosetta Launches US Sales Team
May 5, 2011 / Gene Silencing News - Super Religare Signs Deal to Market Rosetta Genomics’ miRNA Diagnostics
August 20, 2009 / Gene Silencing News - Rosetta Genomics, Prime Health Reach Deal for Coverage of MiRview Mets2 Assay
May 20, 2013 / GenomeWeb Daily News - Rosetta Settles Dispute over Lab Sale
April 18, 2013 / Gene Silencing News